{"product_id":"the-ibm-covid-19-compendium-a-practical-approach-to-effective-pandemic-and-crisis-management","title":"The IBM Covid-19 Compendium: A Practical Approach to Effective Pandemic and Crisis Management","description":"\u003cp\u003e\u003ca rel=\"noopener\" href=\"https:\/\/digital.oempress.com\/1v3vke5\/\" target=\"_blank\"\u003e\u003cimg height=\"61\" width=\"180\" alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0665\/0239\/3945\/files\/EbookButton.jpg?v=1756849029\"\u003e\u003c\/a\u003e\u003ca rel=\"noopener\" href=\"https:\/\/digital.oempress.com\/1v3vke5\/\" target=\"_blank\"\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eAre you responsible for the health and safety of employees? How well are you prepared for the next pandemic or disaster?\u003c\/p\u003e\n\u003cp\u003eAs the SARS-CoV-2 (COVID-19) pandemic surged across the globe in early 2020, businesses of all sizes and their employees were adversely impacted by this swiftly spreading virus. How can workplaces be better prepared for the next pandemic, natural disaster, or man made crisis?\u003c\/p\u003e\n\u003cp\u003eIn \u003cem\u003eThe IBM Covid-19 Compendium\u003c\/em\u003e, IBM’s Global Medical Team shares their experience and lessons learned from a large multi-national company in protecting and preserving the health, safety, and well-being of employees around the world throughout the COVID-19 pandemic. The \u003cem\u003eCompendium\u003c\/em\u003e can also act as a resource for small- and medium-sized companies who need a quick reference guide of policies and practices to help them prepare for the next pandemic or disaster.\u003c\/p\u003e\n\u003cp\u003eFeatures include—\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTechnical safety guidance and considerations around designing workplace policies, organizational controls, and protecting the individual employee\u003c\/li\u003e\n\u003cli\u003eChapters on COVID-19 surges, outbreak support and response, vaccination campaign efforts, as well as reflections and lessons learned\u003c\/li\u003e\n\u003cli\u003eA fully global team of 48 contributors across 18 countries document the diversity of their on-the-ground experiences throughout the pandemic\u003c\/li\u003e\n\u003cli\u003eChapters can be referenced or considered individually as opposed to needing to be read successively\u003c\/li\u003e\n\u003cli\u003eEach chapter opens with specific learning objectives and concludes with questions that assess the readers’ comprehension and mastery of key chapter concepts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you are responsible for the health and safety of workers at a large multi-national organization or part of a team at a small- or medium-sized company, \u003cem\u003eThe IBM Covid-19 Compendium\u003c\/em\u003e provides a truly global, hands-on perspective of how the pandemic unfolded across the world. IBM’s experience can provide a template for your company, large or small, to quickly and flexibly manage the next large-scale global emergency, natural tragedy, or man-made disaster.\u003c\/p\u003e\n\u003cp\u003eRegardless of the size of your organization or availability of a dedicated health and safety team, \u003cem\u003eThe IBM Covid-19 Compendium\u003c\/em\u003e will empower you to have the tools and knowledge to help address a future pandemic or disaster, whether it’s local, regional, or global.\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e\u003cstrong\u003ePublication Date\u003c\/strong\u003e:  2023\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e\u003cstrong\u003eFormat:\u003c\/strong\u003e Softcover, 504 pages.  Also available as an e-book (not downloadable, online access only)\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e\u003cstrong\u003eProduct Code:\u003c\/strong\u003e 23124\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e \u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTABLE OF CONTENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAbout the Editors\u003c\/p\u003e\n\u003cp\u003eList of Contributors\u003c\/p\u003e\n\u003cp\u003ePreface\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eLydia Boyd Campbell, MD, MPH, FACOEM\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eIBM Vice President and Chief Medical Officer\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePART I\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIntroduction\u003c\/p\u003e\n\u003cp\u003eBack in the Beginning: Lessons Learned from IBM in China\u003c\/p\u003e\n\u003cp\u003eTong Chen and Tong Zhang\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #993300;\"\u003e\u003cstrong\u003eSECTION ONE: \u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003eWorkplace Policies\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 1:  \u003c\/strong\u003eDesign and Implementation of the “IBM Return to Workplace Playbook”\u003c\/p\u003e\n\u003cp\u003eAron Hathaway and Vanessa Burrowes\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 2:  \u003c\/strong\u003eRisk Communications and Workplace Closures: Shifting to Work from Home\u003c\/p\u003e\n\u003cp\u003eGabrielle T. Romasanta and Elizabeth Markiewicz\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 3:  \u003c\/strong\u003eClinical Parameters and Considerations for Returning to the Workplace\u003c\/p\u003e\n\u003cp\u003eHarold Louis Trinidad and Juliette Lillian Gonzales\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 4:  \u003c\/strong\u003eIT Solutions to Global Surveillance of Cases\u003c\/p\u003e\n\u003cp\u003eSean A. Allen, Michael Brown, and Vanessa Burrowes\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 5:  \u003c\/strong\u003eContact Tracing, Testing, and Medical Case Management of COVID-19 Cases\u003c\/p\u003e\n\u003cp\u003eRalph Brown and Sean A. Allen\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 6:  \u003c\/strong\u003eTravel Policies, Restrictions, and Meeting and Event Guidance\u003c\/p\u003e\n\u003cp\u003eGriff Warner, Michael Dempsey, and Piotr Błaszczyński\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #993300;\"\u003e\u003cstrong\u003eSECTION TWO: \u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003eOrganizational Controls\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 7:  \u003c\/strong\u003eTemperature and Symptom Screening Prior to Workplace Entry\u003c\/p\u003e\n\u003cp\u003eDavid Smalley and Jeffrey Schmitt\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 8:  \u003c\/strong\u003eGlobal Employee Safety Trainings for On-Site, Technology Support Services, and Essential Workers\u003c\/p\u003e\n\u003cp\u003eTong Chen, Gabrielle T. Romasanta, and Enrique Zepeda Sanchez\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 9:  \u003c\/strong\u003eSocial Distancing On-Site\u003c\/p\u003e\n\u003cp\u003eIni-Abasi Usoro\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 10:  \u003c\/strong\u003eWorkplace Sanitation and Hygiene Practices\u003c\/p\u003e\n\u003cp\u003eDaniel Asaro, Griff Warner, and Ron Burton\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 11: \u003c\/strong\u003eVentilation and Indoor Air Quality\u003c\/p\u003e\n\u003cp\u003ePatton Khuu Nguyen, Michael Dempsey, Griff Warner,\u003c\/p\u003e\n\u003cp\u003eDaniel Asaro, and Karthik Sivaraman\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 12: \u003c\/strong\u003eCOVID-19 Vaccines in the Workplace: To Do or Not to Do. . .\u003c\/p\u003e\n\u003cp\u003eLeslie Kowalski\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #993300;\"\u003e\u003cstrong\u003eSECTION THREE: \u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003eProtecting the Individual Employee\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 13:  \u003c\/strong\u003eCOVID-19 Clinical Virus Testing Methods and Test Evaluation Criteria: COVID-19 Testing Playbook\u003c\/p\u003e\n\u003cp\u003eTong Chen, Carlos Anuar Gomez, Igor Benedick Coimbra, and Thelma Viray\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 14\u003c\/strong\u003e, \u003cstrong\u003eSECTION 1: \u003c\/strong\u003eMask Use as Mitigation for COVID-19 Transmission\u003c\/p\u003e\n\u003cp\u003eVanessa Burrowes and Griff Warner\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 14\u003c\/strong\u003e, \u003cstrong\u003eSECTION 2:  \u003c\/strong\u003eMatching the Mask to the Risk Setting: Decision Tree on Mask Wearing in Countries Returning to Work\u003c\/p\u003e\n\u003cp\u003eVanessa Burrowes and the IBM Corporate Health and Safety Team\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 14\u003c\/strong\u003e, \u003cstrong\u003eSECTION 3: \u003c\/strong\u003eEvaluation Studies of Alternative Mask Models in Occupational Health Settings\u003c\/p\u003e\n\u003cp\u003eMark Zarick, Griff Warner, and David Smalley\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 14\u003c\/strong\u003e, \u003cstrong\u003eSECTION 4: \u003c\/strong\u003eEvaluation of Globally Sourced Masks\u003c\/p\u003e\n\u003cp\u003eDavid Smalley, Griff Warner, and Mark Zarick\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 14\u003c\/strong\u003e, \u003cstrong\u003eSECTION 5: \u003c\/strong\u003eGlobal Management of Supply and Demand for PPE\u003c\/p\u003e\n\u003cp\u003eRon Burton, Michael Dempsey, Aron Hathaway, and Griff Warner\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 15: \u003c\/strong\u003eErgonomic Assessments and Considerations for Work from Home Offices\u003c\/p\u003e\n\u003cp\u003ePatton Khuu Nguyen, Rohini Krishnapillai, and Jenö Hutter\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 16: \u003c\/strong\u003eIt’s Not What You Say, It’s How You Say It—How to Battle Global Pandemic Misinformation\u003c\/p\u003e\n\u003cp\u003eGabrielle T. Romasanta and Elizabeth Markiewicz\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 17: \u003c\/strong\u003eLong COVID: Medical Support and Claims (Long-Term and Short-Term Disability)\u003c\/p\u003e\n\u003cp\u003eGabrielle T. Romasanta, Ini-Abasi Usoro, Ralph Brown, Lydia Boyd\u003c\/p\u003e\n\u003cp\u003eCampbell, and Elizabeth Markiewicz\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 18: \u003c\/strong\u003eMental Health Impacts of Pandemics\u003c\/p\u003e\n\u003cp\u003eCecilie Schultz Pedersen and Anli Yue Zhou\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 19: \u003c\/strong\u003eCOVID-19 Variants and Impacts on Workplace Preparedness\u003c\/p\u003e\n\u003cp\u003eVanessa Burrowes and Igor Benedick Coimbra\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 20: \u003c\/strong\u003eHealth Equity and Diversity Considerations in the Pandemic Context\u003c\/p\u003e\n\u003cp\u003eIni-Abasi Usoro and Lydia Boyd Campbell\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 21: \u003c\/strong\u003eImpacts Due to Delays in Health Care Seeking, Annual Screening, and Chronic Disease Management\u003c\/p\u003e\n\u003cp\u003eKapil Aggarwal and Ini-Abasi Usoro\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 22: \u003c\/strong\u003eDelayed Regulatory Health Exams and Occupational Health Screenings\u003c\/p\u003e\n\u003cp\u003eIgor Benedick Coimbra and Carlos Anuar Gomez\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 23:  \u003c\/strong\u003eIBM Clinical Services in the Time of the COVID-19 Pandemic\u003c\/p\u003e\n\u003cp\u003eMarcy Paul I. Pascua\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 24:  \u003c\/strong\u003eCase Study: Special Management of Business-Critical Operations\u003c\/p\u003e\n\u003cp\u003eDavid Smalley, Ron Burton, Patton Khuu Nguyen,\u003c\/p\u003e\n\u003cp\u003eKarthi Sivaraman, and Mark Zarick\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePART II\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eForeword by Geography Leaders on Regional Pandemic\u003c\/p\u003e\n\u003cp\u003eExperiences\u003c\/p\u003e\n\u003cp\u003eAron Hathaway, Deepak Nanjundaswamy, and Piotr Błaszczyński\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #993300;\"\u003e\u003cstrong\u003eSECTION FOUR: \u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003eCOVID-19 Surges and Outbreak Support and Response\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 25:  \u003c\/strong\u003eGreater China Group Region\u003c\/p\u003e\n\u003cp\u003eTong Chen and Ya Ling Hsu\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 26: \u003c\/strong\u003eAustralia, Southeast Asia, New Zealand, and South Korea (ASEANZK) Region\u003c\/p\u003e\n\u003cp\u003eHarold Louis Trinidad and Marcy Paul I. Pascua\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 27: \u003c\/strong\u003eJapan\u003c\/p\u003e\n\u003cp\u003eKenichi Sunada\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 28: \u003c\/strong\u003eBrazil\u003c\/p\u003e\n\u003cp\u003eIgor Benedick Coimbra and Luciana Maria Carneiro Carvalho Raymundo\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 29: \u003c\/strong\u003eIndia\u003c\/p\u003e\n\u003cp\u003eDeepak Nanjundaswamy\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 30: \u003c\/strong\u003eMexico and Latin America Regions\u003c\/p\u003e\n\u003cp\u003eCarlos Anuar Gomez\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 31: \u003c\/strong\u003eEurope Region\u003c\/p\u003e\n\u003cp\u003eJenö Hutter and Anli Yue Zhou\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 32: \u003c\/strong\u003eMiddle East and Africa Regions\u003c\/p\u003e\n\u003cp\u003eHaithum A. Salloum\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 33: \u003c\/strong\u003eUnited States\u003c\/p\u003e\n\u003cp\u003eRalph Brown\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 34: \u003c\/strong\u003eCanada\u003c\/p\u003e\n\u003cp\u003eAron Hathaway\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #993300;\"\u003e\u003cstrong\u003eSECTION FIVE\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eVaccination Campaign Efforts: First Series, Boosters, and Beyond\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 35: \u003c\/strong\u003eGreater China Group Region\u003c\/p\u003e\n\u003cp\u003eTong Chen and Kai Shen\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 36: \u003c\/strong\u003eAustralia, Southeast Asia, New Zealand, and South Korea (ASEANZK) Region\u003c\/p\u003e\n\u003cp\u003eHarold Louis Trinidad and Marcy Paul I. Pascua\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 37: \u003c\/strong\u003eJapan\u003c\/p\u003e\n\u003cp\u003eKenichi Sunada\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 38: \u003c\/strong\u003eBrazil\u003c\/p\u003e\n\u003cp\u003eIgor Benedick Coimbra and Luciana Maria Carneiro Carvalho Raymundo\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 39: \u003c\/strong\u003eIndia\u003c\/p\u003e\n\u003cp\u003eDeepak Nanjundaswamy\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 40: \u003c\/strong\u003eMexico and Latin America Regions\u003c\/p\u003e\n\u003cp\u003eCarlos Anuar Gomez\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 41: \u003c\/strong\u003eEurope Region\u003c\/p\u003e\n\u003cp\u003eHakan Ozden, Sabine Senecal, and Michael Bestler\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 42:  \u003c\/strong\u003eMiddle East and Africa Regions\u003c\/p\u003e\n\u003cp\u003eHaithum A. Salloum\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 43: \u003c\/strong\u003eUnited States\u003c\/p\u003e\n\u003cp\u003eRalph Brown\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 44: \u003c\/strong\u003eCanada\u003c\/p\u003e\n\u003cp\u003eAron Hathaway\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"color: #993300;\"\u003eSECTION SIX: \u003c\/span\u003eReflections and Lessons Learned from the Global Medical Team\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 45: \u003c\/strong\u003eGreater China Group Region\u003c\/p\u003e\n\u003cp\u003eTong Chen and Ya Ling Hsu\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 46: \u003c\/strong\u003eAustralia, Southeast Asia, New Zealand, and South Korea (ASEANZK) Region\u003c\/p\u003e\n\u003cp\u003eHarold Louis Trinidad and Marcy Paul I. Pascua\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 47: \u003c\/strong\u003eJapan\u003c\/p\u003e\n\u003cp\u003eKenichi Sunada\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 48: \u003c\/strong\u003eBrazil\u003c\/p\u003e\n\u003cp\u003eIgor Benedick Coimbra and Luciana Maria Carneiro Carvalho Raymundo\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 49: \u003c\/strong\u003eIndia\u003c\/p\u003e\n\u003cp\u003eDeepak Nanjundaswamy\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 50: \u003c\/strong\u003eMexico and Latin America Regions\u003c\/p\u003e\n\u003cp\u003eCarlos Anuar Gomez\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 51: \u003c\/strong\u003eEurope Region\u003c\/p\u003e\n\u003cp\u003ePiotr Błaszczyński\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 52: \u003c\/strong\u003eMiddle East and Africa Regions\u003c\/p\u003e\n\u003cp\u003eHaithum A. Salloum\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 53: \u003c\/strong\u003eUnited States\u003c\/p\u003e\n\u003cp\u003eRalph Brown\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHAPTER 54: \u003c\/strong\u003eCanada\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eAron Hathaway\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e \u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: #993300;\"\u003eAFTERWORD: \u003c\/span\u003e\u003c\/strong\u003eStrengthening the Workplace to Prepare for Future Health Risks and Pandemic Threats\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eLydia Boyd Campbell\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eAcknowledgments  \u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eLydia Boyd Campbell and Vanessa Burrowes\u003c\/p\u003e\n\u003cp style=\"line-height: 50%;\"\u003eIndex\u003c\/p\u003e","brand":"OEM Press | OEM Health Information, Inc. | Medical Industry Publisher","offers":[{"title":"Default Title","offer_id":42636714541145,"sku":"23124","price":125.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/0239\/3945\/files\/IBM-Covid-19-Compendium_Cover-flat_110222__21512.webp?v=1756912743","url":"https:\/\/oempress.com\/products\/the-ibm-covid-19-compendium-a-practical-approach-to-effective-pandemic-and-crisis-management","provider":"OEM Press | OEM Health Information, Inc. ","version":"1.0","type":"link"}